What have we been doing?

Read all the latest news from Genevant.

Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis

Posted on 15th March 202112th March 2021

Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine

Posted on 20th January 202120th January 2021

Sarepta Therapeutics and Genevant Sciences to Collaborate for LNP-Based Gene Editing Therapeutics

Posted on 13th January 202120th January 2021

Contact us

We are always ready to connect with people interested in the pioneering work we do.

Get in touch